141 related articles for article (PubMed ID: 7560661)
1. Effect of solution and suspension type aerosol of formoterol on tremor response and airways in patients with asthma.
Bauer K; Sertl K; Kaik B; Kaik G
J Allergy Clin Immunol; 1995 Oct; 96(4):495-501. PubMed ID: 7560661
[TBL] [Abstract][Full Text] [Related]
2. Formoterol suspension aerosol. Comparison with formoterol solution aerosol for 12 weeks in asthmatic patients.
Maesen FP; Nakratzas G; Bantje TA; Prins J; Zweers PG
Chest; 1992 Nov; 102(5):1544-9. PubMed ID: 1424880
[TBL] [Abstract][Full Text] [Related]
3. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A; Lipworth BJ
Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
[TBL] [Abstract][Full Text] [Related]
5. Twelve hours' bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol.
Graff-Lonnevig V; Browaldh L
Clin Exp Allergy; 1990 Jul; 20(4):429-32. PubMed ID: 1973907
[TBL] [Abstract][Full Text] [Related]
6. Objective and subjective bronchodilation over 12 hours after inhaled formoterol: individual responses.
Arvidsson P; Larsson S; Löfdahl CG
J Asthma; 1993; 30(6):459-65. PubMed ID: 8244916
[TBL] [Abstract][Full Text] [Related]
7. Rapid onset of action of inhaled formoterol in asthmatic patients.
Wegener T; Hedenström H; Melander B
Chest; 1992 Aug; 102(2):535-8. PubMed ID: 1353718
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
9. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of different doses of formoterol from a newly developed powder inhalation device in asthmatic patients.
van den Berg BT; Smeets JJ; van Boxtel CJ; Maesen FP
Fundam Clin Pharmacol; 1995; 9(6):593-603. PubMed ID: 8808181
[TBL] [Abstract][Full Text] [Related]
11. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
Wallin A; Sandström T; Rosenhall L; Melander B
Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
[TBL] [Abstract][Full Text] [Related]
13. Formoterol as dry powder inhalation. A dose finding study in comparison with formoterol metered dose inhaler and placebo.
Maesen FP; Costongs R; Smeets SJ; Zweers PG; Goedhart DM
Chest; 1992 May; 101(5):1376-81. PubMed ID: 1582300
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled formoterol versus terbutaline on respiratory function in moderate bronchial asthma.
Hedenström H; Wegener T; Boman G; Wåhlander L; Melander B
Allergy; 1992 Apr; 47(2 Pt 2):158-63. PubMed ID: 1514666
[TBL] [Abstract][Full Text] [Related]
16. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
[TBL] [Abstract][Full Text] [Related]
18. Formoterol and salbutamol metered aerosols: comparison of a new and an established beta-2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma.
von Berg A; Berdel D
Pediatr Pulmonol; 1989; 7(2):89-93. PubMed ID: 2797925
[TBL] [Abstract][Full Text] [Related]
19. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
20. Aerosol fenoterol by intermittent positive pressure breathing in asthmatic patients.
Ruffin RE; Montgomery JM; Newhouse MT
Clin Pharmacol Ther; 1979 Jun; 25(6):821-5. PubMed ID: 376208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
